The trial was tiny, just 16 patients, but it’s eliciting a sentiment not normally associated with this brutal disease of ...

Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following ...

In the seriously great news department, pancreatic cancer is expected to pass colorectal cancer as the second biggest cause ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

A new study from researchers at the Oregon Health and Science University (OHSU) proposes a test called PAC-MANN, which could ...

The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent. Two breakthroughs are ...

Pancreatic cancer remains difficult to treat, and is responsible for around 8 percent of all cancer deaths.It also has one of ...

A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study ...